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ELEVATED ARGININE 
VASOPRESSIN AND 
LOWERED ATRIAL 
NATRIURETIC FACTOR 
ASSOCIATED WITH 
HYPERTENSION IN 
COARCTATION OF 
THE AORTA 
Impairment of humoral and neural regulation of blood pressure may 
contribute to preoperative and postoperative hypertension i coarctation of 
the aorta and may also affect the release of vasopressin and atrial 
natriuretic factor. Because vasopressin and atrial natriuretic factor have 
potent vasoactive ffects, we measured plasma vasopressin and atrial 
natriuretic factor levels by radioimmunoassay before operation and for 5 
days after operation in 11 patients aged 9 months to 12 years undergoing 
coarctation repair and in 12 control patients undergoing other cardiovas- 
cular operations. Six patients in the coarctation group required minimal 
antihypertensive therapy (group 1) and five required prolonged intravenous 
antihypertensive therapy (group II). Before operation, vasopressin levels 
correlated with systolic blood pressure for all patients in the coarctation 
group (r = 0.83, p < 0.01) whereas atrial natriuretic factor levels did not. 
Before operation, atrial natriuretic factor levels were lower (28  - 5 vs 41 + 
7 and 50 -+ 8 pg/mi, p < 0.05) and vasoPressin levels were higher (28 -+ 6 
vs 5.4 -+ 0.9 and 7 +- 3 pg/ml, p < 0.05) in group I I  than in group I or control 
patients. Vasopressin levels were higher (p < 0.05) on the day of operation 
and on postoperative days 2 through 5 in group I I  than in group I and in 
control patients. Atrial natriuretic factor levels were lower during the day 
of operation in group I I  than in group I or in control patients (26 - 7 vs 
51 +-- 16 and 50 +- 7 pg/ml, p < 0.05) and remained lower than control 
values on postoperative days 1 and 3 through 5. Elevated vasopressin and 
lowered atrial natriuretic factor levels may contribute to preoperative and 
postoperative hypertension i  coarctation. (J THORAC CARDIOVASC SURG 
1995;110:900-8) 
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C oarctation of the aorta is commonly associated with hypertension, which is believed to be mul- 
tifactorial in origin. Postulated causes include reno- 
vascular, humoral, vascular, and direct afterloading 
mechanisms.a, 2 Persistent hypertension after repair 
of coarctation is also well described) Explanations 
for postoperative hypertension i clude local vascu- 
lar hyperplasia, 4 vascular hyperactivity, 5 changes in 
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endothelium-dependent relaxation factor, 6'7 and 
abnormalities of renal perfusion, s Alterations of 
baroreceptor, 9 sympathetic nervous system, 1° and 
renin-angiotensin system functions 11-14 have been 
demonstrated. These systems may also interact with 
atrial natriuretic factor (ANF) and vasopressin, 15' 16 
and recent data suggest a role for these vasoactive 
hormones. 17"19 Because vasopressin and ANF have 
potent vasoactive ffects and alterations in plasma 
levels could affect blood pressure in patients with 
coarctation, we studied the relationships among 
ANF, vasopressin, and blood pressure before and 
after repair of coarctation. 
Methods  
Eleven patients aged 9 months to 16 years (median 5.2 
years) undergoing repair of coarctation had plasma vaso- 
pressin and plasma ANF levels measured before opera- 
tion and at specific intervals after operation. Patients 
received a code number assigned by computer during 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 110, Number 4, Part 1 
Stewart et al. 9 0 1 
processing of ANF and vasopressin samples to blind 
assays from clinical data. Before operation, no patients 
were maintained on medication regimens and no patients 
demonstrated findings of congestive heart failure. All 
patients underwent diagnostic atheterization f the left 
and right sides of the heart before operation, and hemo- 
dynamic data from those studies were used for correlation 
with preoperative vasopressin and ANF levels. All pa- 
tients had preoperative systemic hypertension with respect 
to published age-matched standards 2°'2t and had left 
ventricular hypertrophy according to established electro- 
cardiographic or echocardiographic criteria. 22'23 The 
study was approved by the institutional review board at 
New York Medical College and informed consent was 
obtained for each patient. 
Mean right atrial pressures were measured while 
indwelling lines were in place during the sampling 
period. Blood pressure in the right upper extremity was 
measured through radial arterial ines while those were 
in place and subsequently with a manometer cuff. Blood 
pressure in the lower extremities was measured with 
appropriately sized thigh cuffs. All patients had success- 
ful repair of coarctation with equalization of blood 
pressures in the upper and lower extremities after 
operation. No patients had strokes, ischemic bowel 
disease, or vertebral artery syndrome. Patients received 
medications after operation as needed to maintain 
blood pressure at or less than preoperative levels to 
maintain the integrity of the surgical site and to prevent 
postcoarctectomy syndrome. Intravenous nitroprusside 
was used in the early postoperative period; oral capto- 
pril was used afterward, by the second to third postop- 
erative day. Patients who required less than 24 hours of 
intravenous nitroprusside to maintain blood pressure at 
or below preoperative l vels were designated group I; 
patients who required more than 24 hours of this 
treatment were designated group II. Of the group I 
patients, four underwent patch graft repairs, one un- 
derwent subclavian flap repair, and one underwent a 
tube graft from the left subclavian artery to the de- 
scending aorta. Of the group II patients, three under- 
went patch graft repair, one patient underwent end-to- 
end resection, and one underwent a tube graft from the 
left subclavian artery to the descending aorta. 
Twelve children undergoing other heart operations with 
cardiopulmonary b pass served as a control population. 
Diagnoses in the control group included atrial septal 
defect (two), ventricular septal defect (three), aortic ste- 
nosis (two), subaortic stenosis (one), pulmonary stenosis 
(two), and tetralogy of Fallot (two). Ages ranged from 0.8 
to 16.0 years (median 5.7 years). No patients had symp- 
tomatic heart failure or abnormal blood pressure. Two 
patients had been receiving digoxin and furosemide be- 
fore operation. Control patients had undergone diagnos- 
tic catheterization f the right and left sides of the heart 
before operation and had normal right and left atrial 
pressures. Coarctation and control groups received fen- 
tanyl during the induction of anesthesia and fentanyl plus 
halothane during operation. 
ANF and vasopressin assays. Plasma ANF and vaso- 
pressin concentrations were measured before, during, 
and after operation at the following stages: (1) before 
operation, on admission to the hospital (preoperative), 
(2) during operation, after heart repair (intraopera- 
tive), (3) after operation, immediately on entry to the 
recovery room (RR1), (4) later on the day of operation 
while in the recovery area, an average of 6 hours after 
operation (RR2), (5) 1 day after operation (POD1), (6) 
on consecutive days after operation through postoper- 
ative day 5 (POD2, POD3, POD4, and POD5), and (7) 
in six of eight patients in the coarctation group who 
required nitroprusside therapy, blood samples were 
obtained immediately before and within 2 hours after 
the initiation of nitroprusside therapy. Blood samples 
between 2 and 3 ml in volume were taken for hormone 
assay. Preoperative samples were obtained by venipunc- 
ture on admission to the hospital for operation. During 
the first 48 hours after operation, blood was collected 
through an arterial ine. Thereafter blood was collected 
by venipuncture. Each blood specimen was collected in 
a chilled vacuum container containing potassium ethyl- 
enediaminetetraacetic acid and 10 txl/ml blood aproti- 
nin (17 TIU/ml; Ciba Pharmaceutical Co., Summit, 
N.J.). Blood samples were placed on ice immediately. 
Within 3 hours, tubes were spun briefly in a high-speed 
centrifuge; the serum was withdrawn with care to avoid 
the buffy coat, transferred to a second test tube, and 
frozen at -30  ° C to await extraction. 
Hormone assays and extraction. Hormones were ex- 
tracted with octadecyl-silane (Sep-Pak C18; Waters Chro- 
matography Division, MiUipore Corporation, Milford, 
Mass.) by means of a method previously reported: 24'25 
After thawing, plasma samples were acidified to pH 3 with 
1% trifluoroacetic acid to which 8 ml 0.9% sodium 
chloride was added. The cartridge was consecutively acti- 
vated with 8 ml 80% methanol, 10 ml air, 10 ml triethyl- 
amine acetate buffer at pH 4, and another I0 ml air. The 
diluted plasma was added and followed consecutively b  2 
ml 9% sodium chloride, 8 ml double-distilled water, and 
10 ml air. The elution of ANF and vasopressin was 
accomplished by passing 4 ml of a mixture of 1% triflu- 
oroacetic acid and 80% methanol through the column at 
a rate of 1 drop/second. The eluate was lyophilized and 
reconstituted in buffer at a pH of 7.4. 
ANF radioimmunoassay followed the method of Pen- 
insula Laboratories Inc. (Belmont, Calif.) with minor 
modifications. Depending on a priori estimates of concen- 
tration, duplicate samples of 50, 100, or 150 ~1 plasma in 
polypropylene tubes were incubated for 16 hours at 4 ° C 
with 50 t~l ANF antiserum (Peninsula Laboratories) di- 
luted to a final volume of 350 ~1. Iodinated tracer at 8500 
counts/min was added and incubated for another 24 hours 
at 4 ° C. Separation of free and bound fractions was 
accomplished by adding 50 t~l goat antirabbit gamma 
globulin and 50 p.1 normal rabbit serum, incubating for 2 
hours at room temperature, and adding 1.0 ml ice-cold 
polyethylene glycol (30%). The final separation was 
achieved by centrifugation at 1300 g for 30 minutes at 
4 ° C. The pellet was counted twice for 1 minute in a 
gamma counter. The ANF radioimmunoassay standard 
curve ranged from 0.5 to 128 pg/ml. Intraassay variability 
was 4%. Interassay variability was 8%. Percentage xtrac- 
tion has been measured with each previous assay per- 
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formed and has ranged consistently between 75% and 
90%. 24 
Reconstituted samples for vasopressin radioimmunoas- 
say used the method previously reportedY Samples for 
vasopressin were incubated for 24 hours with vasopressin- 
antibody complex (Behring Diagnostics Inc., Somerville, 
N.J.). Vasopressin labeled with iodine 125 (DuPont Diag- 
nostic Imaging Division, North Billevica, Mass.) was 
added in a concentration f 8000 counts/rain, incubated 
for 48 hours with the bound vasopressin-antibody com- 
plex, and then precipitated by the addition of polyethylene 
glycol as indicated for ANF. Tubes were spun in a 
refrigerated centrifuge at 1300 g for 30 minutes and 
radioactivity of the precipitated pellet was counted in a 
gamma counter. The vasopressin radioimmunoassay tan- 
dard curve ranged from 2.5 to 100 pg/ml. Past intraassay 
variability was 4%. Interassay variability was 10%. Per- 
centage xtraction was measured with each previous assay 
performed and has ranged consistently between 90% and 
95%. 25 
Statistical analysis. Means and standard errors of the 
mean were calculated and differences were determined 
by a two-way analysis of variance. Differences at p < 
0.05 were required for statistical significance. Duncan's 
a posteriori test was used to determine intergroup 
differences. 
Results 
Group I comprised six patients and group II 
comprised five patients. Three of the six patients 
in group I required nitroprusside for less than 24 
hours; the remaining three did not require any 
nitroprusside. One of the six patients in group I 
was discharged on a regimen of antihypertensive 
medication. All five patients in group II were 
discharged on regimens of oral antihypertensive 
medications. No relationships between ANF or 
vasopressin and mean right atrial pressure or 
preoperative mean pulmonary capillary wedge 
pressure could be established. For example, on 
postoperative days 1 through 4, right atrial pres- 
sure averaged 4 _+ 1 mm Hg in group I and 5 _-+ 1 
mm Hg in group II. No patients were left without 
oral intake for longer than any others. Fluid 
balance was not associated with changes in ANF 
or vasopressin levels. There was no relationship 
between type of coarctation repair and ANF or 
vasopressin levels. 
ANF as a function of surgical stage. Fig. 1 and 
Table I present mean plasma ANF levels in patients 
undergoing repair of coarctation and control pa- 
tients as a function of preoperative, intraoperative, 
and postoperative stage. Preoperative ANF levels 
and postoperative ANF levels during the first 24 
hours after operation were significantly lower for 
patients in group II than for control patients. ANF 
levels were lower in patients in group II on post- 
operative days 3, 4, and 5 than in control patients. 
ANF levels were also lower in patients in group II 
on postoperative days 4 and 5 than in patients in 
group I. 
Vasopressin as a function of surgical stage. Fig. 
2 and Table I present mean plasma vasopressin 
levels in coarctation and control groups as a 
function of preoperative, intraoperative, and post- 
operative stage. Patients in group I had preoper- 
ative vasopressin levels comparable to control 
levels, whereas patients in group II had preoper- 
ative vasopressin levels markedly elevated with 
respect o control values. Vasopressin levels were 
highest during operation in control patients un- 
dergoing cardiopulmonary bypass and were also 
increased during operation in patients in both 
groups I and II. Vasopressin levels fell rapidly in 
patients in group I and in control patients, return- 
ing to preoperative levels by the second postop- 
erative day. Vasopressin levels were significantly 
higher in group II than in control patients on 
entry to the recovery room and remained elevated 
on postoperative days 2 through 5. Vasopressin 
levels were also significantly higher in group II 
than in group I later on the day of operation and 
on postoperative days 2 through 5. 
Blood pressure. Comparison of preoperative 
blood pressures and preoperative ANF levels 
showed no correlations in any patient group. There 
was, however, a significant correlation (r = 0.83,p < 
0.01) between preoperative plasma vasopressin con- 
centration and blood pressure (Fig. 3). Although 
patients in group II tended to have higher preoper- 
ative blood pressures, the difference between pres- 
sures in groups II and I was not significant (157 -+ 7 
mm Hg for group I1, 134 _+ 7 mm Hg for Group I). 
Postoperative blood pressures were medically con- 
trolled to maintain blood pressure at or lower than 
preoperative l vels, as discussed previously. There 
were therefore no relationships between blood pres- 
sure per se and hormone levels in patients after 
operation. 
Effects of nitroprusside. Nitroprusside was be- 
gun 3 + 2 hours after arrival in the recovery room 
and was administered for 6 + 4 hours in patients 
in group I who received the medication and 40 _+ 
15 hours in patients in group II. No patient 
received nitroprusside during postoperative days 
3 through 5. To determine whether nitroprusside 
administration affected plasma ANF and vaso- 
pressin levels, we measured hormone levels im- 
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Fig. 1. Mean plasma ANF levels as a function of preoperative (Preop), intraoperative (Surgery), and 
postoperative stage are shown. A, Patients with coarctation who requiring prolonged intravenous 
nitroprusside (group II) versus control patients. B, Patients in group II versus patients in group I who did 
not require prolonged nitroprusside therapy. C, group I versus control patients. Asterisks represent 
significant difference at p < 0.05. 
mediately before and within 2 hours after nitro- 
prusside administration i six patients (four of the 
six patients in group II and two of the three 
patients in group I). Results are shown in Fig. 4. 
There was no significant change in vasopressin 
level related to nitroprusside. There was, how- 
ever, a significant (p < 0.05) decrease in ANF 
level after nitroprusside administration. 
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Table I. ANF and vasopressin in coarctation and control groups 
ANF Vasopressin 
Group H Group I Control Group H Group I Control 
Preoperative 28 -- 6* 41 ± 7 50 - 8 28 +__ 6* 5.4 +_ 0.9 7 _+ 3 
Intraoperative 94 _+ 21 36 ± 11 48 ± 8 35 _+ 11 49 ± 29 115 ± 10 
RR1 42 ± 12 30 -+ 5 42 _+ 4 114 _+ 26* 63 ± 15 60 ± 8 
RR2 25_+9" 79±30 55±10 67_+15 32_+8 35_+4 
POD1 26 _ 7* 51 -+ 16 50 _+ 7 31 ± 12 25 ± 14 15 ± 4 
POD2 50_+20 53±14 60±6 30_+9" 8 -2  4+_2 
POD3 33_2"  30_+8 46±3 19±3"  9±2 4±1 
POD4 24±3"  20±1 44_5  21±1"  9_+0.5 3_+2 
POD5 30 --_ 2* 40 _+ 4 50 ± 3 18 ± 1" 10.5 ± 0.5 4 ± 2 
*p < 0.05 compared with control. 
Discussion 
Vasopressin elevation in coarctation patients. 
Our data indicate that vasopressin levels were ele- 
vated before and after operation in patients with 
coarctation in group II who had postoperative hy- 
pertension for the longest ime (Fig. 2). We have 
also shown that preoperative plasma vasopressin 
concentration was correlated with preoperative 
blood pressure in patients with coarctation (Fig. 3). 
Vasopressin may therefore contribute in part to 
preoperative and postoperative hypertension associ- 
ated with coarctation of the aorta. 
Absence of usual stimuli for vasopressin release. 
Stimuli for vasopressin release include hyperosmo- 
larity and stimulation of cardiopulmonary mechano- 
receptors. 26"29 Both low-pressure (e.g., atrial) and 
high-pressure ( .g., ventricular and aortic arch) re- 
ceptors exist. Recent work suggests that high-pres- 
sure receptors may be more important for vasopres- 
sin release in primates and human beings. 3°-32 
Changes in calculated osmolarity did not occur in 
our patients. Hyperosmolality is thus unlikely to 
have been an important stimulus for vasopressin 
secretion in this series. Also, neither stimulation of 
high-pressure ceptors by low systolic pressure nor 
stimulation of low-pressure receptors by low atrial 
pressures occurred in our patients. Patients with 
coarctation had normal atrial pressures and high 
blood pressures, which should have suppressed va- 
sopressin release but did not. The usual regulation 
of vasopressin secretion was therefore absent in 
these patients. 
Nonosmotic regulation of vasopressin depends on 
the sensitivity of cardiopulmonary mechanorecep- 
tors as well as on their degree of stimulation. 
Previous work indicates that alterations in mechano- 
receptor sensitivity do occur in coarctation. Blunted 
baroreceptor function has previously been reported 
both before and after surgical correction of co- 
arctation.9, 10,33,34 Abnormalities in high-pressure 
baroreceptor function are also consistent with our 
previously reported results, 25 in which neonates with 
left ventricular outflow tract obstruction, including 
some with coarctation, were studied. Alterations in 
baroreceptor function may have important effects 
on the release of vasopressin and, because vasopres- 
sin interacts trongly with baroreceptor regulation 
of blood pressure, 35 baroreceptor function may fur- 
ther influence blood pressure control in patients 
with coarctation. Abnormal vasopressin regulation 
could therefore be partially explained by altered 
baroreceptor function in patients with coarctation. 
Decreased ANF in coarctation patients. De- 
creased ANF levels may also have a role in hyper- 
tension in our patients with coarctation. Our data 
indicate that preoperative and postoperative ANF 
levels during the first 24 hours after operation were 
significantly lower in patients in group II than in 
control patients or patients in group I. ANF levels in 
patients in group II were also lower than ANF levels 
in control patients during postoperative days 3 
through 5. Low ANF levels in patients in group II 
early in the postoperative period may have resulted 
in part from decreased preload during nitroprusside 
administration. Nitroprusside was not given before 
operation or during postoperative days 3 through 5, 
and it therefore had no influence on low ANF levels 
at those times. Decreased ANF levels in patients 
with coarctation in group II who had sustained 
postoperative hypertension contrasts with previous 
studies, which showed that ANF levels were in- 
creased by hypertension. 36'37 AlSO, elevated plasma 
vasopressin levels have been shown to increase 
plasma ANF levels. 3s' 39 One would therefore xpect 
ANF levels to be elevated in patients in group II 
with high vasopressin levels. Although a transient 
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perioperative rise in plasma ANF levels did occur 
in patients in group II, ANF levels returned 
rapidly to low preoperative l vels. In patients with 
sustained postoperative hypertension, either an 
abnormality of ANF secretion or a depletion of 
ANF stores may be present. Low plasma ANF 
levels could potentiate hypertension through a 
withdrawal of ANF-induced vasorelaxation and its 
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Fig. 3. The linear elationship between preoperative sys- 
tolic blood pressure (BP) and plasma vasopressin level is 
shown for all patients with coarctation. 
diuretic and natriuretic actions. Low ANF levels 
may also contribute to postoperative hypertension 
by decreasing ANF-induced inhibition of renin 
production, resulting in increased activity of the 
renin-angiotensin system as previously described 
in patients with coarctation. 11-14 
Decrease in ANF but not vasopressin with nitro- 
prusside administration. Postoperative nitroprus- 
side administration did not alter vasopressin levels 
but did decrease ANF levels further. This observa- 
tion is consistent with our current understanding of 
the relation between ANF and atrial stretch15: as 
preload is decreased by nitroprusside, ANF release 
is inhibited by decreasing atrial stretch. Decreased 
blood pressure from nitroprusside administration 
normally would result in increased vasopressin lev- 
els. A lack of change in vasopressin level with 
nitroprusside administration may indicate a dissoci- 
ation of already elevated vasopressin levels from 
usual arterial pressure regulation, as has been also 
been observed in patients with congestive heart 
failure. 4° 
Operative and immediate postoperative vasopres- 
sin elevation. Transient operative and immediate 
postoperative elevations of vasopressin levels were 
observed in all patients and represent a nonspecific 
surgery-related increase in vasopressin level that has 
been reported previously. 4~ As shown in that article, 
vasopressin release depends on the nature of sur- 
gery, with the highest plasma levels of vasopressin 
measured during cardiovascular surgery greater 
than during abdominal surgery, in turn greater than 
during superficial surgery. The surgical response is 
further increased by cardiopulmonary bypass 42" 43 as 
56 
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Fig. 4. Effects of nitroprusside. Plasma ANF levels (top 
panel) and vasopressin (AVP) levels (bottom panel) imme- 
diately before (Pre-NP) and 2 hours after (Post-NP) 
nitroprusside administration in six patients. 
in our control group. Our control group is therefore 
a maximal control in the sense that it controls for 
the highest expected thoracic surgery-related vaso- 
pressin levels, as shown in Fig. 2. Nevertheless, 
except for patients with coarctation in group II 
vasopressin levels returned rapidly to normal evels 
within 24 hours after operation. The nonspecific 
response to surgery therefore cannot explain the 
differences observed among our subject groups. 
Rather, the data support he hypothesis that preop- 
erative and postoperative hypertension i coarcta- 
tion of the aorta may result in part from the pressor 
effects of vasopressin. 
Similarly, all patients received opiates for anes- 
thesia nd analgesia, nd it is known that opiates can 
affect vasopressin release. Naloxone in particular 
has been shown to suppress the nonspecific surge in 
vasopressin associated with surgery. 44 Fentanyl, on 
the other hand, exerts a permissive ffect on vaso- 
pressin increase, 45which is not significantly different 
from that of halothane alone. 44 All patients received 
similar postoperative morphine treatment for pain. 
As noted previously, however, except for patients 
with coarctation i  group II, vasopressin levels re- 
turned rapidly to normal. An opiate response there- 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 110, Number 4, Part 1 
Stewart et al. 9 0 7 
fore cannot account for the differences measured 
between the groups. 
Changes in the site of blood sampling, from 
venous before operation to arterial during the peri- 
operative period to venous again after operation, 
may have affected measured ANF levels because 
plasma ANF levels are known to be somewhat 
higher in arterial than in venous blood in human 
beings. 46'47 Nevertheless, differences in sampling 
site could not account for the differences in ANF 
levels between patients with coarctation i  groups II 
and I or between patients in group I I  and control 
patients because blood samples were collected the 
same way for all. 
Summary 
In summary, our data indicate that elevated 
plasma vasopressin levels in the absence of an 
expected increase in plasma ANF levels occurs in 
patients with coarctation of the aorta. These hor- 
monal changes may contribute to preoperative and 
to sustained postoperative hypertension observed in 
some patients with coarctation of the aorta. 
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